United Therapeutics Corporation (UTHR)
Debt-to-assets ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | 300,000 | 800,000 | 800,000 | 800,000 | 600,000 |
| Total assets | US$ in thousands | 7,167,000 | 6,044,500 | 5,169,100 | 4,615,000 | 3,913,400 |
| Debt-to-assets ratio | 0.04 | 0.13 | 0.15 | 0.17 | 0.15 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $300,000K ÷ $7,167,000K
= 0.04
The debt-to-assets ratio of United Therapeutics Corp has shown a declining trend over the past five years, decreasing from 0.22 in 2019 to 0.10 in 2023. This indicates that the company is relying less on debt to finance its operations and investments relative to its total assets. A lower debt-to-assets ratio suggests a lower financial risk and a stronger ability to withstand economic downturns. It also signifies a healthier balance sheet as the company is less burdened by debt obligations in relation to its asset base. Overall, the decreasing trend in the debt-to-assets ratio of United Therapeutics Corp is a positive indication of the company's financial health and prudent financial management.
Peer comparison
Dec 31, 2023